Durvalumab (D) +/- tremelimumab (T) plus platinum-etoposide (EP) in 1L extensive-stage (ES) SCLC: characteristics of long-term survivors in the CASPIAN study
Tarih
2022Yazar
Xie, Mingchao
Chen, Yuanbin
Hotta, Katsuyuki
Poltoratskiy, Artem
Hochmair, Maximilian J.
ÖZGÜROĞLU, Mustafa
Ji, Jun Ho
Statsenko, Galina
Voitko, Oleksandr
Conev, Nikolay V.
Bondarenko, Igor
Mann, Helen
Bischoff, Helge
Paz-Ares, Luis
Dalvi, Tapashi
Chugh, Priti
Shrestha, Yashaswi
Goldman, Jonathan W.
Garassino, Marina Chiara
Üst veri
Tüm öğe kaydını gösterKoleksiyonlar
- Makale [92796]